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Abstract
Background Since 1995, the association of type D person-
ality and mortality in patients with cardiovascular diseases
has been increasingly investigated.
Purpose The aim of this meta-analysis was to integrate
conflicting results and to examine possible moderators of
this association.
Methods Prospective studies assessing type D personality
and hard endpoints were selected and pooled in meta-
analyses. Cardiovascular diagnosis, type and quality of ad-
justment, and publication date were examined in moderator
analyses.
Results Twelve studies on patients with cardiovascular dis-
eases (N05,341) were included. Pooled crude and adjusted
effects demonstrated a significant association of type D
personality and hard endpoints (odds ratio (OR) of 2.28
(95% CI [1.43–3.62]), adjusted hazard ratio (HR) of 2.24
(95% CI [1.37–3.66])). The OR decreased over time (OR
5.02 to OR 1.54). There was no association in congestive
heart failure patients.
Conclusions More recent methodologically sound studies
suggest that early type D studies had overestimated the
prognostic relevance.
Keywords Meta-analysis . Cardiovascular disease . Type D
personality . Mortality
Introduction
Sixteen years ago, the first study on the association of type
D personality with a higher mortality rate in patients with
coronary artery disease (CAD) was published [1], marking a
milestone regarding the potential influence of personality
characteristics on physical health in behavioral medicine.
Type D personality refers to the “distressed” personality
type and is characterized by the interaction of two traits: a
high level of negative affectivity and a high level of social
inhibition [2]. Since that time, this personality trait has been
increasingly investigated and discussed as an independent
risk factor for the prognosis of patients with heart disease.
Five reviews that included hard endpoints have been
published since then; among these are two narrative reviews
[2, 3] and three systematic reviews [4–6]. All these reviews
consistently concluded that type D personality is associated
with an increased risk of adverse cardiac events. However,
methodological shortcomings of earlier reviews weaken this
conclusion substantially. The first critical point is related to
the definition of hard endpoints, which is a core condition
for validity. Reich and Schatzberg selected studies with
standardized measures of physical illness as endpoints—
including health-related quality of life, arrhythmias, success
of heart surgery, and cardiac events—for their meta-analysis
[4]. Even the most recent meta-analyses [5, 6], which were
restricted to prognostic studies with hard endpoints, included
composite endpoints of major cardiac events, including revas-
cularization. A second point to consider is that all studies
analyzed in earlier reviews were conducted in Denollet’s work
group and were based exclusively on samples from The
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Netherlands and Belgium. In the review by Denollet and
colleagues [5], data turned out to be subsamples [7, 8] of a
more comprehensive study [9, 10], which were included in
duplicate in the meta-analysis. Because the literature search of
earlier reviews was limited to February 2009 [6], the most
recent studies with very large samples were not considered
[11–13]. Since research on type D has become more popular
in recent years, other work groups have conducted prognostic
studies on type D. Therefore, these more recent results from
primary studies should be taken into consideration to strengthen
the overall findings and conclusions on the prognostic effect of
type D in patients with cardiovascular diseases.
The aims of our systematic review were to examine
whether an updated meta-analysis including more recent
observational studies and studies with conflicting results
would replicate earlier results on the relation of type D
personality with hard endpoints in patients with cardiovas-
cular diagnoses. Only mortality and nonfatal cardiac events
were considered as endpoints to improve validity. Subgroup
analyses were conducted to examine the influence of addi-
tional study characteristics on the association of type D and
patient prognosis. These study characteristics refer to (a) the
type of cardiovascular diagnoses (CAD vs. congestive heart
failure (CHF)) as they might be associated with different
causal links of type D and pathogenesis, (b) the type and
quality of adjustment (i.e., psychological factors, biological
factors, social/sociodemographic factors) as there exist large
differences with regard to the number and kind of variables
included in multivariate models that could be related to
effect sizes of type D, and (c) the publication date of the
study as later studies are often methodologically more
sound.
Materials and Methods
Inclusion Criteria
Our systematic review and meta-analysis included prospec-
tive cohort studies with a baseline assessment of type D and
adverse outcomes such as mortality (all cause, cardiac) or a
combination of mortality and nonfatal cardiac events. The
study sample had to consist of patients with any type of
cardiovascular disorder (i.e., CAD, CHF, peripheral artery
disease, arrhythmias). No restrictions on sample size, length
of follow-up, publication date, and language of publication
were applied.
Information Sources and Literature Search
The literature search covered PubMed (US National Library
of Medicine, 1950–2011/08) (n0117 references), PsycInfo
(American Psychological Association, 1966–2011/08)
(n016 references), Embase (Excerpta Medica Database,
1990–2011/08) (n087 references), and Web of Science
(Social Science Citation Index, 1900–2011/08) (n0121 refer-
ences). Specific search strategies were developed for each
database (e.g., for Pubmed: “distressed personality” OR “type
d” OR “social inhibition” AND “mortality”). We searched for
additional studies by a hand search of reference lists and
earlier reviews on type D personality (n01 reference).
Study Selection and Data Collection
All results were downloaded and stored with the software
Reference Manager. From a total of 342 references, 195
unique references remained after deletion of duplicates.
These references were screened for eligibility by title and
abstract; the resulting papers were retrieved and consulted in
full text. Reasons for exclusion were coded. For data extrac-
tion, an electronic extraction sheet was used. Descriptive
information on setting, type of assessment of type D, sample
characteristics, and data on effect measures (odds ratios
(OR), hazard ratios (HR)) were extracted. All papers were
coded independently by two raters (GG, MR). Disagree-
ments were resolved by consensus with a third reviewer
(JB).
Extracted Data
Type D Personality
We accepted all assessment instruments for the classification
of type D personality. We needed a dichotomous classifica-
tion of type D vs. non-type D personality.
Variables Used in Adjusted Models
We extracted whether the authors used socio-demographic
(e.g., age, gender, education level), biological (e.g., cardio-
vascular risk factors, left ventricular ejection fraction), and
psychological variables (e.g., depressive mood, anxiety) in
adjusted analyses.
Outcomes
We extracted three different outcomes: (1) all-cause mortal-
ity, (2) cardiac death, and (3) a composite measure including
nonfatal myocardial infarction and cardiac death. Data
on surgical procedures such as angioplasty or bypass
surgery were not considered because these procedures
rely also on subjective and clinical decisions. In the meta-
analysis, we analyzed only one type of outcome according to a
pre-specified hierarchy (1 preferred over 2 and 2 preferred
over 3).
300 ann. behav. med. (2012) 43:299–310
Data Analysis
The effects of type D personality on the prognosis of cardiac
patients were included in the meta-analysis as odds ratios. If
adjustments were done, adjusted hazard ratios (HRadj) were
used. These HRadj more precisely represent the net effect of
type D personality on mortality or morbidity. For both effect
measures, corresponding confidence intervals (CI) were
used to estimate the precision of the effect. If results were
presented by a two-by-two table, we separately calculated
OR values. All statistical analyses were done with STATA
11 by the command metan [14]. The reported summary
statistics were calculated both as fixed and random effects
models. Fixed effects models weigh studies according to
their measurement error only, whereas random effects
models take into account the heterogeneity between
studies and give studies more equal weight. Pooling
was done according to the DerSimonian and Laird
method [15] using the inverse variances of the primary
studies. Cumulative meta-analysis was used to take into
account the publication year of the study. The CI rep-
resents 95% ranges, which indicate a statistically signif-
icant effect when values of 1.0 are excluded from the
OR or adjusted HR values. Values of OR or HRadj
above 1.0 indicate a negative association between type D
personality and prognosis of the cardiovascular disease.
Heterogeneity between studies was assessed by examining
forest plots of studies, by calculating a chi-square heterogene-
ity test, and through I² statistics. The chi-square value indi-
cates heterogeneity if statistical significance is found. In
addition, higher I² values indicate greater variability between
studies than would be expected by chance alone (range 0–
100%); Higgins and colleagues [16] proposed values of 25%,
50%, and 75% as indicators of low, moderate, and high
heterogeneity. Publication bias was explored by funnel plots
and the Egger test for small study effects [17].
We limited our analysis to one outcome measure per study.
The effect of adjustments was explored by selecting studies
that adjusted for socio-demographic, biological, or psycholog-
ical variables in the analysis. An additional sensitivity analysis
was conducted for studies that adjusted for all three dimen-
sions in their analyses. This procedure was intended to
achieve more homogeneous results since the same mediating
variables were included in the primary study.
Results
Study Selection
Of the 195 publications, 146 were excluded by title and
abstract. The resulting 49 papers were retrieved in full text.
Another 28 papers were excluded after consultation of the
full text. Twenty-one papers were included in the systematic
review. For each of the 174 excluded papers, the reasons for
exclusion were coded: 88 papers referred to a different,
biologically defined “type D,” 28 papers were nonempirical,
30 were based on a cross-sectional design, 25 used other
endpoints, two papers assessed social inhibition but not type
D personality [18, 19], and one paper was based on a sample
with a diagnosis other than cardiovascular disease [20].
Of the 21 papers included in the systematic review, two
reported secondary analyses on pooled data from studies
already published [21, 22]. An additional five papers re-
ferred to results from a subsample or pilot study and were
excluded, too [1, 7, 8, 23, 24]. This selection procedure
resulted in a final number of 14 papers (see Fig. 1).
Twelve studies were published in 14 papers [9–13, 25–33].
Some papers referred to identical patient samples. Thus, two
papers [26, 29] were merged and labeled as “Denollet et al.,
2006” [26], and two papers [10, 27] were merged into “Ped-
ersen et al., 2004” [10] (due to a more detailed description of
results and the earlier publication date, respectively). This
resulted in a total number of 12 studies (Table 1). In one study,
only univariate statistics were available [26], and therefore the
adjusted HR was based on 11 studies. Six studies were carried
out in The Netherlands [10, 11, 13, 30–32], four in Belgium
[9, 25, 26, 28], one in Switzerland [33], and one in Germany
[12]. All papers were published in English. Five studies ana-
lyzed a consecutive sample of patients with CAD [9, 10, 25,
26, 31]; one of these was restricted to patients admitted to a
hospital due to acute myocardial infarction [31]. In the other
four studies, CAD patients were recruited in the rehabilitation
center within 2 months after acute myocardial infarction,
bypass surgery, or percutaneous transluminal coronary angio-
plasty. Three studies enrolled patients with chronic heart fail-
ure [11, 13, 33]. One study enrolled patients with mixed
cardiac diagnoses (CAD, structural heart disease, arrhythmias)
[12], and one study included patients with peripheral arterial
disease [30]. Two samples were recruited after a medical
intervention: heart transplantation [28] and first implantable
cardioverter defibrillator [32], respectively. Mean length of
follow-up ranged between 9 months and 7.9 years. Sample
sizes at enrollment ranged from 51 to 1,040 participants. All
studies included participants of both genders; the proportion
of women was between 8% and 38%. The mean ages of study
samples ranged from 54.1 to 70.7 years. Type D prevalence
varied from 13.5% to 35%. Type D personality was assessed
by a combined index from the subscale Social Inhibition of
the Heart Patient Psychological Questionnaire [7, 9, 34] and
the State-Trait Anxiety Inventory [35] in one study [9] and by
the DS16 in two studies [25, 26]. All other studies used the
DS14 [2]. The outcome most often assessed was all-cause
mortality in eight studies [9, 11–13, 28, 30, 32, 33]; three
studies used cardiac mortality as the outcome [9, 13, 25], and
four studies used a composite index of nonfatal myocardial
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infarction and cardiac death [25, 26, 31, 32]. The number and
type of variables used in the multivariate regression models
varied considerably (Table 2). All studies except three [9, 11,
33] controlled for age. Only two of 11 studies did not adjust
for any biological variables [28, 30]. Six of 11 studies con-
trolled for at least one psychological variable [9, 11–13, 25,
31].
Crude Effects of Type D Personality on Prognosis
Using a fixed effects model, the association between type D
personality and hard endpoints (mortality or combined in-
dex of cardiac mortality and nonfatal myocardial infarction)
was supported with an OR of 1.54 (95% CI [1.26–1.89])
(see Fig. 2). An analysis on the cumulative OR ranked
according to the publication date yielded a continuously
decreasing relation between type D and prognosis starting
at 5.02 (95% CI [2.47–10.21]) and going down to 1.54 (see
Fig. 3). Applying a random model resulted in an OR of 2.28
(95% CI [1.43–3.62]) (see Fig. 4). There was marked het-
erogeneity between studies (χ2045.41; df011; p<0.001;
I2075.8%). Additional analyses were conducted to examine
the results for publication bias. The Egger test for bias
indicated a significantly larger effect for small studies (t0
4.02; p00.002). A visual exploration of the funnel plot
showed that eight studies with moderate sample sizes
342 records
through database searching
195 records 
after duplicates removed
195 records screened 
by title and abstract
146 records excluded;
wrong topic: 88
non-empirical article: 28
cross-sectional design: 30
1 record
through handsearch
49 full-text articles 
assessed for eligibility
28 articles excluded;
wrong endpoints: 25
no assessment of type D: 2
wrong diagnosis: 1
21 eligible full-text articles
12 studies (14 articles) included
in qualitative synthesis
9 articles excluded;
secondary analyses: 2
subsamples of other articles.: 5
identical samples: 2
12 studies included
in quantitative synthesis
Fig. 1 Flow chart for the
selection of studies after initial
search
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showed large effects, whereas three studies with large sam-
ple sizes showed effects close to a null finding, which is
visualized by the regression line in “Electronic Supplemen-
tary Material”—Fig. a1.
Adjusted Effects of Type D Personality on Prognosis
In studies assessing the association of type D personality
and prognosis with adjustment for other risk factors, there
was a significant adjusted HRadj of 2.24 (95% CI [1.37–
3.66]) in a random effects model (see Fig. 5). Heterogeneity
between studies was considerably high (χ2046.51; df010;
p00.001; I2078.5%). Similar to the unadjusted odds ratios,
results of a fixed model meta-analysis confirmed a smaller
effect of HRadj 1.60 (95% CI [1.29–1.97]). Analyses for
publication bias again demonstrated a significant small
study effect in the Egger test (t03.34; p00.009) for adjusted
studies (see “Electronic Supplementary Material”—Fig. a2).
Subgroup Analyses
We performed additional random effects subgroup analyses
to examine whether quality of adjustment and the main
diagnosis of the study sample altered the results. For studies
adjusting for socio-demographic variables, HRadj was 2.65
(95% CI [1.49–4.69]; I2077.7%) [10, 12, 13, 25, 28,
30–32]. In studies controlling for biological variables,
HRadj was 2.02 (95% CI [1.20–3.41]; I2080.6%) [9–13,
25, 31–33]. The pooled effect for the six studies that con-
trolled for psychological symptoms no longer showed an
independent effect of type D with an HRadj of 1.83 (95% CI
[0.99–3.37]; I2083.8%) [9, 11–13, 25, 31]. Also, if we
included only those studies that adjusted for all three dimen-
sions of control variables, a nonsignificant effect resulted
(HRadj 1.92 (95% CI [0.91–4.05]); I2082.7%) [12, 13, 25,
31].
The diagnosis of CAD turned out to be a potential mod-
erator of the association of type D personality and progno-
sis. In samples of CAD patients [9, 10, 25, 31], we found a
larger prognostic effect (p<0.0006) of type D personality
(HRadj 3.88 (95% CI [2.58–5.85]); I2046.3%) compared to
studies with CHF patients [11, 13, 33] (HRadj 0.91 (95%
[CI 0.66–1.27]); I200%).
Discussion
Our study confirmed a significant association between type
D personality and mortality and nonfatal myocardial infarc-
tion. However, the initially published odds ratios decreased
over time, and heterogeneity between studies was very
large, which raises concerns about the robustness of the
NOTE: Weights are from random effects analysis
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Fig. 4 Forest plot of prognostic studies on assessing the effect of type D personality on mortality/nonfatal myocardial infarction in patients with
cardiovascular disorders. Random effects model. Odds ratios unadjusted. N012
306 ann. behav. med. (2012) 43:299–310
effect. The problem of heterogeneity between studies was
not reported in earlier meta-analyses [4–6] and partly caused
by the integration of the most recent studies with large
samples and null findings. These most recent studies included
patients with CHF. This raises the questions on whether type
D personality does not affect prognosis in CHF or whether
larger studies give more precise estimates. A publication bias
was found with very large effects in small studies and lower or
null effects in the largest studies. The publication bias still
holds if studies on CHF patients are excluded. This has
important consequences for the interpretation of the results
from the two statistical models we used (fixed effects vs.
random effects). In fixed effects models, the sample size is
represented in the weight of the study, whereas in the random
effects meta-analyses, small studies receive more weight.
When assessing very large effects of small studies, the mean
pooled effect may be overestimated in random effects models,
and a fixed effect model may lead to a more appropriate effect
size estimate because the study size is better represented. Both
analyses arrived at about the same results regarding the lower
confidence interval, which were 1.3 and 1.4, and showed
significant effects in both models. The size of the effect may
be between an OR of 1.5 and 2.3 depending on the statistical
procedure used, but for a conservative interpretation, the
lower number would be more appropriate.
Whereas earlier reviews [5, 6] yielded a pooled effect of
3.72 and 3.16, respectively, our study provided a much more
conservative estimate of the adverse effects of type D, which
is comparable to other psychosocial variables such as depres-
sion, anxiety, and social support, which are about 1.5 to 2.4
[36–42]. In the fully adjusted model, an HR of 1.92 was
found, which is in the expected direction of a higher risk for
type D patients, but it failed to reach the level of significance.
Similarly, studies controlling for psychological variables dem-
onstrated a nonsignificant pooled effect size. Here, some con-
founding and multicollinearity in the multivariate analyses
must be assumed [43] as negative affectivity as a primary
emotional factor is very closely associated with subordinate
emotional constructs such as anxiety and depression [44, 45].
Differentiating specific negative emotions as well as distin-
guishing states from traits regarding negative affect is seen as
important for improving the understanding of the mechanisms
that link emotions with cardiopathogenetic processes [46].
Significant overlaps of measurements and constructs make it
difficult to identify whether specific emotions are indepen-
dently associated with CAD risk or whether additive or inter-
active effects are more adequate model assumptions [46]. The
statistical control for symptoms of anxiety and depression in
multivariate models may lead to an attenuation of social
inhibition, which does not correspond with the original con-
ceptual idea of type D personality.
The diagnosis of the sample was important for the associ-
ation between type D and prognosis. In CAD patients, a large
effect was demonstrated, whereas null effects were found in
NOTE: Weights are from random effects analysis
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studies with CHF [11–13, 33]. The latter finding is contrary to
findings using other psychological characteristics such as
depression, which was found to be predictive of mortality
and secondary events in CHF patients in a meta-analysis
[47]. Our results probably suggest that type D patients with
different cardiac diseases carry a different risk for their prog-
nosis. This is clinically relevant as prevalence estimates of
type D personality across CAD and CHF subsamples are quite
similar (15–29% and 14–33%, respectively) [48].
Pathogenetical mechanisms that link type D to adverse
outcomes in cardiovascular diseases are still unclear. Cross-
sectional studies provide some evidence for inflammation
and dysfunctions in stress regulation via the hypothalamic–
pituitary–adrenal axis as mechanisms involved in the path-
way from type D to unfavorable medical outcomes [6].
However, the cross-sectional design and the overall small
number of studies limit the available evidence substantially.
The prognostic effects of type D studies have decreased
considerably across time. It seems that the concept is losing
power comparable to the concept of the type A pattern
(characterized by hard driving and competitive behavior)
decades before [49–52]. Recently, Ioannidis and Panagiotou
demonstrated patterns of diminishing relations for most of
35 biomarkers after a prominent highly cited early publica-
tion. The editor’s motivation to be the first to report on a
specific association might neglect problems with small sam-
ple sizes [53]. In type D research, a comparable situation
may have led to an initial overestimation of the association
between type D and prognosis. Our study is another exam-
ple of an effect that has declined over time.
Our review cannot overcome some serious methodolog-
ical shortcomings in type D research [43]. The first issue is
related to the practice of dichotomization of the interaction
of negative affectivity and social inhibition that is seen as
the core concept of the type D personality. Evidence is
lacking with regard to the validity of the type D vs. non-
type D construct and the merging of the three non-type D
groups into one [54, 55]. Furthermore, our meta-analysis is
based on effect sizes reported for a dichotomous operation-
alization of the type D personality. Dichotomization may be
inadequate for translating the specific interactional character
of the type D construct [43]. The general limitations of
dichotomizing continuous variables are well known: It
may reduce the sensitivity of statistical tests and produce
spurious associations [56–58]. Even for the type D measure-
ment, a dimensional operationalization rather than a cate-
gorical structure is supported [59]. Because a “natural”
category of type D personality cannot be demonstrated
empirically, type D research should incorporate continuous
scores of negative affectivity and social inhibition and their
interaction into statistical analyses instead of the dichoto-
mous construct [43]. At any rate, three of the inclusive
studies [11–13] also tested the interaction between
continuous negative affectivity and social inhibition dimen-
sions and found no evidence for the predicted association.
Lastly, in the smaller studies, the number of events observed
is often small, especially relative to the number of covariates
included in the multivariate models, which can result in
over-fitting and insufficient parameter estimation [60].
Limitations
Our study has several limitations that should be mentioned.
First, the included studies were only observational and caus-
al conclusions might be inadequate [61]. Recruitment strat-
egies or data on drop-outs were often not described in detail.
In some of the subgroup analyses, the number of remaining
studies was very small. We found large heterogeneity be-
tween studies, which means that the pooled estimate must be
interpreted with caution. Unfortunately, heterogeneity could
not be reduced by limiting the study pool to studies with the
same variables used for adjustment. However, we found a
homogeneous null effect in patients with CHF. A publica-
tion bias was present, and smaller studies reported a consid-
erably larger effect of type D on prognosis. The number of
published studies is still limited and there are limitations in
the methodological quality of the type D operationalization
in previous research.
To conclude, our meta-analysis supports the overall find-
ing of an association between the type D personality and
prognosis with data from 12 independent samples with a
total of 5,341 cardiovascular patients. However, the strength
of this association has been declining over the years and
studies with high methodological rigor failed to confirm this
association. The review suggests that type D personality
affects prognosis only in CAD patients but not in patients
with CHF. Pre-registered observational studies [62] with an
adjustment of biological, social, and psychological charac-
teristics on patients with CAD are urgently required to give
clear clinical guidance regarding whether these patients are
really at risk.
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